Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia

被引:41
作者
Oishi, Tomohiro [1 ,3 ]
Narita, Mitsuo [2 ]
Matsui, Kou [1 ]
Shirai, Takahiro [1 ]
Matsuo, Mai [1 ]
Negishi, Jun [1 ]
Kaneko, Takayuki [1 ]
Tsukano, Shinya [1 ]
Taguchi, Tetsuo [1 ]
Uchiyama, Makoto [3 ]
机构
[1] Niigata Prefectural Shibata Hosp, Dept Pediat, Shibata, Niigata 9578588, Japan
[2] Sapporo Tokushukai Hosp, Dept Pediat, Shiroishi Ku, Sapporo, Hokkaido 0030021, Japan
[3] Niigata Univ, Div Pediat, Dept Homeostat Regulat & Dev, Grad Sch Med & Dent Sci, Niigata 9518510, Japan
关键词
Interleukin-18 (IL-18); Lactate dehydrogenase (LDH); Mycoplasma pneumoniae; Child; Pneumonia; COMMUNITY-ACQUIRED PNEUMONIA; PULMONARY-DISEASE; INFECTION; CHILDREN; LUNG;
D O I
10.1007/s10156-011-0265-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The immunological pathogenesis of Mycoplasma pneumoniae pneumonia is known to involve several cytokines. The serum levels of interleukin-18 (IL-18) were examined using enzyme-linked immunosorbent assay in 23 pediatric patients (median age 6 years; range 4-13 years; 14 girls and 9 boys) with M. pneumoniae pneumonia admitted to our hospital. Serum levels of IL-18 ranged from 22 to 1808 pg/ml with a mean of 543 pg/ml. We started steroid therapy in two cases with IL-18 values greater than 1000 pg/ml without being aware of IL-18 levels. Examination of associations between IL-18 levels determined by enzyme-linked immunosorbent assay and a routine laboratory test showed that levels of lactate dehydrogenase (LDH) and IL-18 were significantly correlated. To determine the appropriateness of steroid administration in M. pneumoniae pneumonia patients, serum LDH should be examined. Patients with elevated levels of LDH are likely to have significantly elevated IL-18 values (a parts per thousand yen1000 pg/ml) and thus can be candidates for steroid therapy.
引用
收藏
页码:803 / 806
页数:4
相关论文
共 15 条
[1]   Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells [J].
Hoek, KL ;
Cassell, GH ;
Duffy, LB ;
Atkinson, TP .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (03) :470-476
[2]  
Hsieh Chia-Chang, 2001, Journal of Microbiology Immunology and Infection, V34, P109
[3]  
Iwata Atsuko, 2007, Kansenshogaku Zasshi, V81, P586
[4]   Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children [J].
Lee, KY ;
Lee, HS ;
Hong, JH ;
Lee, MH ;
Lee, JS ;
Burgner, D ;
Lee, BC .
PEDIATRIC PULMONOLOGY, 2006, 41 (03) :263-268
[5]   IL-1 beta and IL-6 in community-acquired pneumonia: Bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia [J].
Lieberman, D ;
Livnat, S ;
Schlaeffer, F ;
Porath, A ;
Horowitz, S ;
Levy, R .
INFECTION, 1997, 25 (02) :90-94
[6]   Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection [J].
Llibre, JM ;
Urban, A ;
Garcia, E ;
Carrasco, MA ;
Murcia, C .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (06) :1340-1342
[7]   Current concepts - Community-acquired pneumonia in children [J].
McIntosh, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06) :429-437
[8]   Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon [J].
Narita, M ;
Tanaka, H ;
Abe, S ;
Yamada, S ;
Kubota, M ;
Togashi, T .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (06) :909-914
[9]   Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection [J].
Narita, M ;
Tanaka, H ;
Yamada, S ;
Abe, S ;
Ariga, T ;
Sakiyama, Y .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (05) :1028-1030
[10]  
ROLLINS S, 1986, ARCH PATHOL LAB MED, V110, P34